(Q53322341)

13 May 2018

title

Decreased mRNA expression of CCL5 [RANTES] in Alzheimer's disease blood samples. (English)

1 reference

13 May 2018

1 reference

4

1 reference

13 May 2018

Wiesje van der Flier

object named as

Wiesje M van der Flier

2

0 references

Philip Scheltens

5

object named as

Philip Scheltens

1 reference

13 May 2018

1

Maartje I Kester

1 reference

13 May 2018

Cees B M Oudejans

6

object named as

Cees B Oudejans

1 reference

13 May 2018

author name string

Allerdien Visser

3

1 reference

13 May 2018

publication date

23 September 2011

1 reference

13 May 2018

Clinical Chemistry and Laboratory Medicine

published in

1 reference

13 May 2018

volume

50

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

61-65

1 reference

13 May 2018

CSF markers for incipient Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

No correlation between time-linked plasma and CSF Abeta levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

Evaluation of plasma Abeta40 and Abeta42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

CSF biomarker levels in early and late onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.731

21 January 2018

Identifiers

DOI

10.1515/CCLM.2011.731

1 reference

13 May 2018

1 reference

13 May 2018